(2R,3R,4R,5S,6S)-2-(AcetoxyMethyl)-6-(4-chloro-3-(4-ethoxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate NEW

Anhui Lianchuang Biological Medicine Co., Ltd ( hereinafter referred to as "The Company" ), was established in 2009 and headquartered in the west of Fanhua Avenue, Hefei Economic and Technological Development Zone. The company is a national high-tech enterprise with the mission of serving health and pursuing technical contribution. It is an innovative technology company providing products and technical services to consumers and global pharmaceutical manufacturers. The company's current main business is pharmaceutical APIs and characteristic intermediates. The company has several subsidiaries, which are engaged in the R&D and production of pharmaceutical APIs and intermediates, preparations MAH, diabetes control devices and food development, etc.